Benefits of bandage contact lenses plentiful

Article

Therapeutic bandage contact lenses (CLs) can be successfully used in the management of a variety of corneal and anterior segment disorders, said Valerie Seligson, OD, here at the 5th annual Evidence Based Care in Optometry conference.

Baltimore-Therapeutic bandage contact lenses (CLs) can be successfully used in the management of a variety of corneal and anterior segment disorders, said Valerie Seligson, OD, here at the 5th annual Evidence Based Care in Optometry conference.

Clinical proof

Several clinical studies have shown that a variety of bandage soft CLs are safe and effective, according to Dr. Seligson. Lim et al. (CLAO J. 2001;27:179-185), for example, conducted a trial in 54 consecutive patients to assess the efficacy of a bandage soft CL (PureVision, Bausch + Lomb Inc) for filamentous keratopathy, corneal perforation or laceration, stromal melting, recurrent corneal erosion, epithelial defect due to trauma or chemical burn, bullous keratopathy, persistent epithelial defect, post-penetrating keratoplasty, and post-photorefractive keratectomy (PRK).

In 40 patients with corneal wounds, 96% had improved healing, while 83% experienced full healing with the bandage soft CL. For pain relief (n = 28 eyes), the bandage soft CL brought full pain relief in 96% and partial pain relief in 4%. The bandage soft CL provided 100% corneal protection with only 1 complication, which was comprised of culture negative corneal infiltrate, and 1 patient with poorly fitting contact lens.

Guard against infection

"A major downside of using a bandage lens is getting an infiltrate. It's very rare, less than 1% to 2%," said Dr. Seligson. "To prevent this when using any bandage soft CL, patients must be seen often and the lens used only short-term (3 to 30 days). Patients must also be educated on the signs and symptoms of infection, and told to call immediately if they develop."

Researchers of a larger prospective study (Eye Contact Lens. 2004;30:63-67) assessed the use of a bandage soft CL (Night & Day, Ciba Vision) in 70 patients, 47 of whom had bullous keratopathy. Lenses were used for 7 to 30 days as continuous wear, with 91% showing improvements in healing and 94% rating their comfort as good.

Newer studies, newer CLs

In another more recent study in 100 patients who underwent PRK (J Cataract Refract Surg. 2005;31:681-686), researchers did a masked comparison of silicone hydrogel lotrafilcon A (Night & Day [8.4/8.6 base curve, 13.8 diameter], Ciba Vision) and etafilcon A (Acuvue 8.4/8.8, 14.0, Vistakon Inc.) extended-wear bandage CLs after PRK. Patients were fitted with 1 of each lens post-PRK. The lotrafilcon A lens resulted in faster corneal re-epithelialization and reduced subject patient discomfort in most patients during the first 48 hours after PRK. Dr. Seligson noted that this study was conducted with the Acuvue etafilcon A CL; Acuvue now has a therapeutic bandage CL (Acuvue Oasys, Vistakon Inc.) made of senofilcon A, which would most likely have a different outcome, she said.

In the final clinical trial cited by Dr. Seligson (Am J Ophthalmol. 2000;130:25-32), researchers studied a rigid gas permeable scleral CL in 49 consecutive patients (76 eyes). Patients had Stevens-Johnson syndrome, exposure keratitis, superior limbic keratoconjunctivitis, Sjögren's syndrome, and inflammatory corneal degeneration. A full 92% of patients had improvement in quality of life due to reduction of their discomfort and photophobia. Patients in the trial were able to wear these scleral lenses from 4 to 18 hours, and the mean wearing time of these lenses was 13.7 hours per day.

"Studies show that the bandage is most often used with disposable soft [CLs] for short-term use and, on average, 91% of patients achieve clinical success," Dr. Seligson said in conclusion. "Lens failure was most likely due to dry eye, lens loss, CL deposit, and rarely, corneal infection."

FYI

Valerie Seligson, ODPhone: 410/310-2330
E-mail:vseligs1@jhmi.edu

Dr. Seligson has no financial disclosures.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Brett Bielory, MD, at ASCRS 2025
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
© 2025 MJH Life Sciences

All rights reserved.